abstract |
【Task】 Further development of wound healing promoting agents is expected. [Solution] According to the present invention, steviol glycosides selected from rebaudioside A and rebaudioside M for promoting wound healing, promoting H2S production, treating conditions ameliorated by H2S , promoting NO production and/or for the treatment of conditions ameliorated by NO. [Selection figure] None |